Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
2.
World J Surg Oncol ; 6: 12, 2008 Jan 31.
Article in English | MEDLINE | ID: mdl-18237404

ABSTRACT

BACKGROUND: Adenocarcinoma of the small bowel is a relatively rare malignancy as compared to the other malignancies of the gastrointestinal tract. Nonspecific presentation and infrequent occurrence often leads to a delay in diagnosis and consequent poor prognosis. Various other factors are of prognostic importance while managing these tumors. METHODS: The medical records of a total of 27 patients treated for adenocarcinoma of the small bowel at Providence Hospital and Medical Centers from year 1990 through 2003 were reviewed retrospectively. Data were analyzed using SPSS software (version 10.0; SPSS, Inc., Chicago, IL). Survival analyses were calculated using the Kaplan Meier method with the log rank test to assess the statistical significance. The socio-demographics (age, gender) were calculated using frequency analyses. RESULTS: The patients included nine males and eighteen females with a median age at diagnosis of 62 years. Only 48% of the patients had an accurate preoperative diagnosis while another 33% had a diagnosis suspicious of small bowel malignancy. None of the patients presented in stage 1. The cumulative five-year survival was 30% while the median survival was 3.3 years. There was no 30-day mortality in the postoperative period in our series. CONCLUSION: The univariate analysis demonstrated that tumor grade, stage at presentation, lymph nodal metastasis and resection margins were significant predictors of survival.


Subject(s)
Adenocarcinoma/mortality , Adenocarcinoma/surgery , Intestinal Neoplasms/mortality , Intestinal Neoplasms/surgery , Intestine, Small/pathology , Adenocarcinoma/pathology , Aged , Anastomosis, Surgical , Cohort Studies , Disease-Free Survival , Female , Humans , Immunohistochemistry , Intestinal Neoplasms/pathology , Kaplan-Meier Estimate , Laparotomy/methods , Male , Middle Aged , Neoplasm Staging , Probability , Prognosis , Retrospective Studies , Risk Assessment , Survival Analysis , Time Factors , Treatment Outcome
3.
J Trauma ; 55(1): 118-25, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12855890

ABSTRACT

BACKGROUND: Hemorrhagic shock-related leukocyte adherence to endothelial cells is a key step in microvascular injury-related organ damage. Heme-oxygenase-1 (HO-1) metabolizes heme, a potent cytotoxic agent, to carbon monoxide and biliverdin. We hypothesized that changing HO-1 expression would change leukocyte adherence after hemorrhagic shock. METHODS: Rats were administered hemin, zinc protoporphyrin, or vehicle 6 hours before surgery. HO-1 expression was determined by reverse-transcriptase polymerase chain reaction in various tissues. Shock was induced in urethane-anesthetized animals by decreasing mean arterial blood pressure to 40 mm Hg for 60 minutes, followed by standard resuscitation measures. Leukocyte adherence was measured by intravital microscopy in rat mesenteric venules. RESULTS: Hemin, hemorrhagic shock, and the combination resulted in significantly increased HO-1 expression, whereas zinc-protoporphyrin (ZNPP) resulted in significantly decreased leukocyte adherence. After hemorrhagic shock and hemin administration, leukocyte adherence was significantly decreased 60 minutes into resuscitation (7.92 +/- 2.29 vs. 4.84 +/- 0.71 cells/100 microm, p < 0.05) and significantly increased after ZNPP plus shock (14.08 +/- 3.95, p

Subject(s)
Heme Oxygenase (Decyclizing)/physiology , Hemin/metabolism , Shock, Hemorrhagic/metabolism , Animals , Cell Adhesion , Gene Expression Regulation , Heme Oxygenase (Decyclizing)/genetics , Heme Oxygenase-1 , Hemin/physiology , Male , RNA, Messenger/genetics , Rats , Rats, Sprague-Dawley , Receptors, Leukocyte-Adhesion/drug effects , Reverse Transcriptase Polymerase Chain Reaction
4.
Shock ; 18(5): 423-7, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12412620

ABSTRACT

The generation of oxygen radicals during leukocyte-endothelial cell interaction is considered to represent one of the fundamental steps of microvascular injury following ischemia and reperfusion. Indirect evidence also suggests that this relationship may be important following hemorrhagic shock. The purpose of this study was to characterize the temporal changes of reactive oxygen species (ROS) in the mesenteric microvascular endothelium, in vivo, as a consequence of hemorrhagic shock and reperfusion, and to correlate this ROS production to leukocyte adherence. Following a control period, blood was withdrawn to reduce the mean arterial pressure to 40 mmHg for 1 h in urethane-anesthetized rats. Mesenteric venules in a transilluminated segment of small intestine were examined to quantitate changes in ROS generation and leukocyte adherence. Sprague-Dawley rats were injected with dihydrorhodamine 123, a hydroperoxide-sensitive fluorescent probe that is trapped within viable cells as a nonfluorescent form and then converted to the mitochondrion-selective form rhodamine 123 by hydroperoxides. The fluorescent light emission from rhodamine 123 was recorded with digital microscopy and downloaded to a computerized image analysis program. Our results demonstrated an 80% increase in ROS generation beginning within 5 min into resuscitation and a 10-fold increase in leukocyte adherence that occurred at 10 min after resuscitation. Both ROS generation and leukocyte adherence were attenuated with pre-shock administration of platelet activating factor (PAF) antagonist, WEB 2086, and the CD11/CD18a antibody, anti-LFA-1beta. Our findings suggest that ROS production in endothelial cells is increased during reperfusion following hemorrhagic shock and that the mechanism of expression is mediated in part by both PAF expression and subsequent leukocyte adherence.


Subject(s)
Endothelium, Vascular/pathology , Leukocytes/pathology , Reactive Oxygen Species/metabolism , Shock, Hemorrhagic/metabolism , Shock, Hemorrhagic/pathology , Animals , Azepines/pharmacology , Cell Adhesion , Fluorescent Dyes , Lymphocyte Function-Associated Antigen-1/physiology , Male , Microcirculation/injuries , Microcirculation/metabolism , Microcirculation/pathology , Platelet Activating Factor/antagonists & inhibitors , Rats , Rats, Sprague-Dawley , Reperfusion Injury/metabolism , Reperfusion Injury/pathology , Resuscitation , Rhodamines , Triazoles/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...